Farther Finance Advisors, LLC Rigel Pharmaceuticals Inc Transaction History
Farther Finance Advisors, LLC
- $2.67 Trillion
- Q3 2024
A detailed history of Farther Finance Advisors, LLC transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 667 shares of RIGL stock, worth $10,058. This represents 0.0% of its overall portfolio holdings.
Number of Shares
667Holding current value
$10,058% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RIGL
# of Institutions
10Shares Held
345KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY323KShares$4.86 Million0.76% of portfolio
-
Barclays PLC London, X010.6KShares$159,4400.0% of portfolio
-
Bergan Kdv Wealth Management, LLC10KShares$150,8000.0% of portfolio
-
Ifp Advisors, Inc1KShares$15,0800.0% of portfolio
-
Nelson, Van Denburg & Campbell Wealth Management Group, LLC Omaha, NE126Shares$1,9000.0% of portfolio
About RIGEL PHARMACEUTICALS INC
- Ticker RIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 172,836,000
- Market Cap $2.61B
- Description
- Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...